The pharmaceutical landscape for diabetes is shifting, and transdermal GLP-1 delivery systems represent a promising advance. Unlike injections, this technique offers a simpler way to provide GLP-1 drugs. These https://amaannmul189526.angelinsblog.com/39795941/glp-1-patches-a-novel-approach-to-blood-sugar-management